Literature DB >> 7483794

Immunity to diphtheria in the 4-70 year age group in Italy.

M Wirz1, M Puccinelli, C Mele, G Gentili.   

Abstract

Diphtheria antibody level in serum samples obtained from 270 subjects aged 4-70 was measured by in vitro seroneutralization test on Vero cells. Of the studied population, 27.8% had an antibody titre below the protective level (< 0.01 IU/ml). The prevalence of susceptible subjects showed a significant age-related increase (p < 0.01), with the highest value (53.8%) in the 31-40 age group. Mean antibody titre was maximum in individuals aged 13-14, then decreased reaching the minimum level in the 41-50 age group. These data suggest that in individuals aged 30-50, diphtheria immunity is not satisfactory, both for prevalence of immune subjects and for antibody levels. Therefore, a revaccination of adults with reduced doses of diphtheria toxoid may be advisable.

Mesh:

Substances:

Year:  1995        PMID: 7483794     DOI: 10.1016/0264-410x(94)00051-n

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Immunity to diphtheria in a sample of the Canadian adult population.

Authors:  L Pelletier; P Duclos; P Gill; A Deforest
Journal:  Can J Infect Dis       Date:  1998-11

2.  Diphtheria immunity in Flanders.

Authors:  C Matheï; P Van Damme; P Bruynseels; H Goossens; R Vranckx; A Meheus
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-09       Impact factor: 3.267

3.  Immunity to diphtheria in Izmir, Turkey.

Authors:  A Egemen; Z Kurugöl; S Akşit; T Ozacar; P Keskinoğlu; I Afşar
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

4.  The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV).

Authors:  P Laroche; M Barrand; S C Wood; K Van Hasbrouck; J Lang; E Harzer; L Hessel
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 7.455

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.